84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]龔家川.影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險因素分析[J].中醫(yī)正骨,2017,29(06):25-27.
 GONG Jiachuan.Analysis of risk factors for affection of hip joint in patients with ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):25-27.
點(diǎn)擊復(fù)制

影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險因素分析()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期數(shù):
2017年06期
頁碼:
25-27
欄目:
臨床研究
出版日期:
2017-06-20

文章信息/Info

Title:
Analysis of risk factors for affection of hip joint in patients with ankylosing spondylitis
作者:
龔家川
河南省商丘市第一人民醫(yī)院,河南 商丘 476100
Author(s):
GONG Jiachuan
The First People's Hospital of Shangqiu,Shangqiu 476100,Henan,China
關(guān)鍵詞:
脊柱炎強(qiáng)直性 髖關(guān)節(jié) 危險因素
Keywords:
Key words spondylitisankylosing hip joint risk factors
摘要:
目的:探討影響強(qiáng)直性脊柱炎(ankylosing spondylitis,AS)患者髖關(guān)節(jié)受累的危險因素,為臨床早期干預(yù)提供依據(jù)。方法:回顧性分析94例AS患者的臨床資料,根據(jù)髖關(guān)節(jié)是否受累分為髖關(guān)節(jié)受累組(36例)和髖關(guān)節(jié)未受累組(58例)。觀察受累髖關(guān)節(jié)的具體情況,并比較2組患者的發(fā)病年齡、紅細(xì)胞沉降率(erythrocyte sedimentation rate,ESR)、血清C反應(yīng)蛋白(C-reactive protein,CRP)含量、血清免疫球蛋白G(immunoglobulin G,IgG)含量、Schober試驗(yàn)值及枕墻距。結(jié)果:36例髖關(guān)節(jié)受累患者中,單側(cè)髖關(guān)節(jié)受累7例、雙側(cè)髖關(guān)節(jié)受累29例,其中37個股骨頭囊性變、26個股骨頭壞死、21個髖關(guān)節(jié)間隙變窄、8個髖關(guān)節(jié)纖維性強(qiáng)直或骨性強(qiáng)直。與髖關(guān)節(jié)未受累組相比,髖關(guān)節(jié)受累組的發(fā)病年齡低、ESR高、血清CRP含量和IgG含量高、Schober試驗(yàn)值低、枕墻距大[(21.3±2.7)歲,(31.5±5.0)歲,t=5.584,P=0.028;(47.7±29.4)mm·h-1,(31.6±12.7)mm·h-1,t=5.692,P=0.024;(52.8±31.5)mg·L-1,(33.2±23.6)mg·L-1,t=7.013,P=0.015;(29.8±10.2)g·L-1,(14.9±7.2)g·L-1,t=8.826,P=0.009;(2.4±0.9)cm,(3.2±0.7)cm,t=4.942,P=0.039;(16.3±4.4)cm,(10.2±3.8)cm,t=6.975,P=0.018]。結(jié)論:發(fā)病年齡低、ESR高、血清CRP含量和IgG含量高、Schober試驗(yàn)值低、枕墻距大,均可能是影響AS患者髖關(guān)節(jié)受累的危險因素。
Abstract:
ABSTRACT Objective:To explore the risk factors for affection of hip joint in patients with ankylosing spondylitis(AS)so as to provide evidence for early clinical intervention.Methods:The medical records of 94 patients with AS were analyzed retrospectively,and the patients were divided into affected hip joint group(36 cases)and unaffected hip joint group(58 cases).The affected hip joints were observed and the age of onset,erythrocyte sedimentation rate(ESR),the serum content of C-reactive protein(CRP)and immunoglobulin G(IgG),Schober values and pillow-wall distance were compared between the 2 groups.Results:Unilateral affected hip joint(7 cases)and bilateral affected hip joint(29 cases)were found in 36 patients.The hip joint damages included cystis degeneration of femoral head(37),femoral head necrosis(26),narrowed hip joint space(21)and fibrous ankylosis or bony ankylosis of hip joint(8).Compared with patients in unaffected hip joint group,patients in affected hip joint group had a lower onset age,higher ESR,higher serum contents of CRP and IgG,lower Schober values and longer pillow-wall distance(21.3+/-2.7 vs 31.5+/-5.0 years,t=5.584,P=0.028; 47.7+/-29.4 vs 31.6+/-12.7mm/h,t=5.692,P=0.024; 52.8+/-31.5 vs 33.2+/-23.6 mg/L,t=7.013,P=0.015; 29.8+/-10.2 vs 14.9+/-7.2g/L,t=8.826,P=0.009; 2.4+/-0.9 vs 3.2+/-0.7 cm,t=4.942,P=0.039; 16.3+/-4.4 vs 10.2+/-3.8 cm,t=6.975,P=0.018).Conclusion:Lower onset age,higher ESR,higher serum contents of CRP and IgG,lower Schober experimental values and longer pillow-wall distance may be risk factors for affection of hip joint in patients with AS.

參考文獻(xiàn)/References:

[1] 劉越,趙艷梅,夏群.強(qiáng)直性脊柱炎的診斷與治療進(jìn)展[J].中國矯形外科雜志,2015,23(3):235-238.
[2] MAGREY MN,KHAN MA.The paradox of bone formation and bone loss in ankylosing spondylitis:evolving new concepts of bone formation and future trends in management[J].Curr Rheumatol Rep,2017,19(4):17.
[3] 趙穎.強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的臨床特征分析[J].臨床合理用藥雜志,2016,9(16):145-147.
[4] 蔣明,朱立平,林孝義.風(fēng)濕病學(xué)[M].北京:科學(xué)出版社,1995:446-581.
[5] 劉慶寬,成明華,熊波,等.全髖關(guān)節(jié)置換術(shù)在治療強(qiáng)直性脊柱炎受累髖關(guān)節(jié)中的應(yīng)用[J].湘南學(xué)院學(xué)報(醫(yī)學(xué)版),2010,12(1):29-31.
[6] 李洪毓,陳宜恒.強(qiáng)直性脊柱炎髖關(guān)節(jié)病變的相關(guān)因素分析[J].中華風(fēng)濕病學(xué)雜志,2010,14(11):756-758.
[7] VANDER CRUYSSEN B,MUÑOZ-GOMARIZ E,FONT P,et al.Hip involvement in ankylosing spondylitis:epidemiology and risk factors associated with hip replacement surgery[J].Rheumatology(Oxford),2010,49(1):73-81.
[8] 陳芳妮.強(qiáng)直性脊柱炎髖關(guān)節(jié)病變的影像學(xué)研究[D].廣州:南方醫(yī)科大學(xué),2014. 中醫(yī)正骨2017年6月第29卷第6期 J Trad Chin Orthop Trauma,2017,Vol.29,No.6(總427) (總428)中醫(yī)正骨2017年6月第29卷第6期 J Trad Chin Orthop Trauma,2017,Vol.29,No.6
[9] CALIN A,ELSWOOD J,RIGG S,et al.Ankylosing spondylitis-an analytical review of 1500 patients:the changing pattern of disease[J].J Rheumatol,1988,15(8):1234-1238.
[10] XIA Q,FAN D,YANG X,et al.Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis:A systematic review and meta-analysis[J].Medicine(Baltimore),2017,96(4):e5960.
[11] LEE EJ,LEE EJ,CHUNG YH,et al.High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation[J].Arthritis Res Ther,2015,17:350.
[12] HERREGODS N,DEHOORNE J,PATTYN E,et al.Diagnositic value of pelvic enthesitis on MRI of the sacroiliac joints in enthesitis related arthritis[J].Pediatr Rheumatol Online J,2015,13(1):46.
[13] 王剛,王炎焱,朱劍,等.感染性骶髂關(guān)節(jié)炎21例臨床分析[J].中華內(nèi)科雜志,2015,54(5):420-425.
[14] 蔡顏嶸,徐衛(wèi)東.基于強(qiáng)直性脊柱炎骨化相關(guān)信號通路探討其炎癥與骨化的關(guān)系[J].中華風(fēng)濕病學(xué)雜志,2015,19(6):428-431.
[15] Qu Z,Qian BP,Qiu Y,et al.Does the position of conus medullaris change with increased thoracolumbar kyphosis in ankylosing spondylitis patients?[J].Medicine(Baltimore),2017,96(6):e5963.

相似文獻(xiàn)/References:

[1]閻曉霞,任之強(qiáng),仝允輝,等.布魯氏菌性脊柱炎3例[J].中醫(yī)正骨,2015,27(06):64.
[2]趙偉光,劉振武,劉利,等.強(qiáng)直性脊柱炎合并右側(cè)股骨頭和股骨頸骨溶解癥1例[J].中醫(yī)正骨,2015,27(01):75.
[3]黃建武,黃建華,黃影.腫瘤壞死因子-α在強(qiáng)直性脊柱炎活動期患者中的表達(dá)[J].中醫(yī)正骨,2013,25(11):22.
[4]張董喆,孔超,張建福.針刺夾脊穴結(jié)合督灸治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2014,26(07):58.
[5]吳建國.強(qiáng)直性脊柱炎并發(fā)脊柱骨折的影像學(xué)表現(xiàn)[J].中醫(yī)正骨,2013,25(06):31.
[6]謝國華,薛峰,楊建平,等.強(qiáng)直性脊柱炎脊柱應(yīng)力性骨折的診斷[J].中醫(yī)正骨,2012,24(12):72.
[7]張萬義,張永紅,王笑青.雙醋瑞因膠囊聯(lián)合柳氮磺胺吡啶腸溶片與右旋布洛芬膠囊治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2012,24(06):26.
 ZHANG Wan-yi*,ZHANG Yong-hong,WANG Xiao-qing.*.Study on the curative effects of diacerein capsules combined with sulfasalazine enteric-coated tablets and dextral ibuprofen capsules in the treatment of ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):26.
[8]黃建華,黃建武,陳金春,等.早期強(qiáng)直性脊柱炎血管內(nèi)皮生長因子、C反應(yīng)蛋白 表達(dá)水平的臨床研究[J].中醫(yī)正骨,2012,24(02):9.
 HUANG Jian-hua*,HUANG Jian-wu,CHEN Jin-chun,et al.Clinical research on the expression of VEGF、CRP in early ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):9.
[9]王笑青,張永紅,王玉麗,等.常規(guī)藥物口服配合中藥離子導(dǎo)入治療強(qiáng)直性脊柱炎肌腱附著點(diǎn)炎[J].中醫(yī)正骨,2011,23(10):18.
 WANG Xiao-qing*,ZHANG Yong-hong,WANG Yu-li,et al.A study on the curative effects of oral conventional drugs combined with traditional Chinese medicine iontophoresis on ankylosing spondylitis tendon enthesitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(06):18.
[10]劉紅軍.單節(jié)段楔形截骨結(jié)合椎弓根A-F系統(tǒng)內(nèi)固定 治療強(qiáng)直性脊柱炎脊柱后凸畸形[J].中醫(yī)正骨,2011,23(09):65.
[11]戴霞華,李寅潔.指導(dǎo)性功能鍛煉在兒童強(qiáng)直性脊柱炎護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2015,27(10):78.
[12]張夢雨,鮑鐵周,田江波.督脈隔姜灸聯(lián)合柳氮磺吡啶腸溶片口服及 功能鍛煉治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2015,27(09):44.
[13]赫軍,諸葛天諭,李冬冬,等.中藥內(nèi)服聯(lián)合針刺與埋針法治療幼年強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(01):41.
[14]赫軍,諸葛天諭,李冬冬,等.四聯(lián)療法治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(06):50.
[15]張遂連,袁星星.自我管理在強(qiáng)直性脊柱炎患者門診護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2017,29(03):79.
[16]李現(xiàn)林,薛華珍,陳星,等.口服通痹舒筋丸治療強(qiáng)直性脊柱炎寒濕痹阻證[J].中醫(yī)正骨,2017,29(05):31.
[17]黃小龍,全仁夫,胡華輝,等.HLA-B2704基因型強(qiáng)直性脊柱炎患者來源的人誘導(dǎo)多能干細(xì)胞體系的建立[J].中醫(yī)正骨,2017,29(12):11.
 HUANG Xiaolong,QUAN Renfu,HU Huahui,et al.Establishment of human-induced pluripotent stem cells system originated from patients with HLA-B2704 genotypic ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):11.
[18]李洛宜,張依山,王笑青,等.系列化視頻在強(qiáng)直性脊柱炎健康教育中的應(yīng)用[J].中醫(yī)正骨,2018,30(03):78.
[19]任偉凡,胡勁濤,全仁夫,等.強(qiáng)直性脊柱炎易感基因的相關(guān)研究進(jìn)展[J].中醫(yī)正骨,2019,31(04):48.
[20]楊愛娟,徐保平,王曉濤.新風(fēng)膠囊治療強(qiáng)直性脊柱炎臨床療效的系統(tǒng)評價[J].中醫(yī)正骨,2020,32(07):12.
 YANG Aijuan,XU Baoping,WANG Xiaotao.Clinical efficacy of Xinfeng(新風(fēng))capsule for treatment of ankylosing spondylitis:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(06):12.

更新日期/Last Update: 2017-06-20